AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025

Amgen (NASDAQ:AMGN) today announced that new data from its cardiovascular portfolio, including late-breaking results from the Phase 3 VESALIUS-CV clinical trial of Repatha® (evolocumab), will be ...

Global Plywood Market Led by Furniture, With Paneling and Cladding Applications Growing 5.66% CAGR to 2030: Mordor Intelligence

Plywood market demand rises as consumers and manufacturers embrace natural aesthetics, durable furnishings, and lightweight materials for modern interior applications.Hyderabad, India, Oct. 31, 2025 ...